Brii Biosciences Limited BRIBF
0.13 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.2312 Day range 0.2459
0.12575 52-week range 0.2459
- YTD
- -30.37%
- 1 year
- -45.97%
Financial health
Altman Z-Score
10.76 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 5
Valuation
P/E -4.4×
FY 2019 5y median -4.4× FY 2025
P/S 52.0×
FY 2019 5y median 82.9× FY 2025
P/B 0.4×
FY 2019 5y median 0.4× FY 2025
P/FCF -3.3×
FY 2019 5y median -3.3× FY 2025
EV/EBITDA -1.2×
FY 2019 5y median -4.2× FY 2025
EV/Sales 18.9×
FY 2019 5y median 52.3× FY 2025
FCF Yield -30.6%
FY 2019 5y median -30.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin -1632.6%
FY 2019 5y median -995.3% FY 2025
Net Margin -1196.6%
FY 2019 5y median -1196.6% FY 2025
ROE -9.1%
FY 2019 5y median -15.2% FY 2025
ROIC -12.7%
FY 2019 5y median -16.2% FY 2025
ROA -9.2%
FY 2019 5y median -14.3% FY 2025
Growth (YoY)
Revenue -63.7%
FY 2019 FY 2025
Operating Income 26.7%
FY 2019 FY 2025
EPS (diluted) 57.1%
FY 2019 FY 2025
Free Cash Flow 23.3%
FY 2019 FY 2025
Financial Health
Current Ratio 60.7×
FY 2019 5y median 22.1× FY 2025
Quick Ratio 60.7×
FY 2019 5y median 22.1× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 2.1×
FY 2019 5y median 2.5× FY 2025
Interest Coverage -155×
FY 2019 5y median -520× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31